Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1411 of 5804
-
Engineered immune cells take on Hard-to-Treat colon cancer
Disease control Recruiting nowThis study aims to determine the safety and best response of treatment with CNA3103 (Leucine-rich repeat-containing G protein-coupled receptor 5 \[LGR5\]-targeted, Autologous Chimeric Antigen Receptor (CAR) -T Cells), for participants with Metastatic Colorectal Cancer. Participa…
Phase: PHASE1, PHASE2 • Sponsor: Carina Biotech Limited • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowTo find the recommended dose of TROP2- CAR-NK cells that can be given to participants with advanced forms of solid tumors.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a shingles shot protect transplant patients? timing may be key.
⭐️ VACCINE ⭐️ Recruiting nowThis research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the eff…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:02 UTC
-
Radiation zaps spots to keep chemo working longer
Disease control Recruiting nowThis study assesses if metastasis-directed radiation therapy (Stereotactic body radiation therapy - SBRT) can delay a change in systemic therapy, and if circulating tumor cells in the bloodstream can help guide treatment options in metastatic breast cancer patients with progressi…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for Obesity-Linked endometrial cancer: experimental combo enters human trials
Disease control Recruiting nowEndometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to rise, in part due to the obesity epidemic. Obese women with EC have a 6.3-fold increased risk of death from this disease, as compared …
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail shows promise for tough lung cancer cases
Disease control CompletedThe main objective of this study was to evaluate the anti-tumor activity of gimistotug (BGB-A445) plus investigational agents in participants with non-small cell lung cancer (NSCLC).
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a single infusion stop GPP flares in their tracks?
Disease control OngoingThis study is open to adults with a serious skin disease called generalized pustular psoriasis (GPP) who have repeated flares of GPP. The purpose of this study is to find out whether a medicine called spesolimab helps people with repeated flares of GPP. Participants are given a …
Phase: PHASE4 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New pain block could help chest trauma patients breathe on their own sooner
Symptom relief Recruiting nowBlunt chest trauma is commonly associated with rib fractures and early pain management is a key goal after chest trauma. In spontaneous breathing patients, pain limits coughing efficiency and secretion clearance, thereby potentially leading to progressive atelectasis, loss of fun…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can a 4-Week online program help college students beat insomnia?
Symptom relief CompletedCollege students experience higher rates of insomnia compared the general population, and accessibility and availability for the appropriate intervention is difficult due limited resources available to them in a college environment. Theorefore, it is vital to offer an interventio…
Phase: NA • Sponsor: Utah State University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New cell patch could ease knee arthritis pain without replacement
Disease control Recruiting nowTo evaluate the efficacy and safety of CLS2901C human allogenic chondrocyte sheets used in the osteotomy + RMSC group compared to in the osteotomy alone group of patients with osteoarthritis of the knee (OAK).
Phase: PHASE3 • Sponsor: CellSeed Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New shot shows promise against tough skin cancer
Disease control OngoingThe purpose of this study is to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) pembrolizumab (+) berahyaluronidase alfa in Japanese participants with recurrent or metastatic cutaneous squamous cell carcinoma or locally advanced unresectable cSCC. The primary…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for kids with resistant tumors: drug combo enters safety trial
Disease control OngoingThe purpose of this study is to find out whether avutometinib is a safe treatment for advanced or recurrent solid tumor cancers in children and young adults. Researchers will look for the highest dose of avutometinib that is safe and cause few or mild side effects.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could diabetes meds help women with PCOS get pregnant?
Disease control CompletedThe aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.
Phase: PHASE4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New balloon treatment could open clogged small heart arteries without stents
Disease control Recruiting nowProspective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in s…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for men with Hard-to-Treat prostate cancer?
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Mentoring dads: a new way to stop violence and boost child development?
Disease control OngoingThe goal of this stepped-wedge cluster randomized control trial is to assess whether a Ugandan community-based intervention for young fathers (ages 18-25 years) of children ages 0-3 years impacts fathers' knowledge, attitudes, and behaviors surrounding positive parenting practice…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New heart scan could replace invasive artery probes
Diagnosis CompletedA prospective, confirmatory, multicenter, open-label clinical investigation of a Class IIa medical device (in accordance with Article 62 of Regulation 2017/745), conducted to confirm the performance of the Cardiolens® Platform, which is based on a non-invasive, combined anatomica…
Sponsor: Hemolens Diagnostics Sp. z o.o. • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Simple hygiene steps could curb cholera outbreaks
Prevention Recruiting nowObjective: The investigators objective is to develop and evaluate the effectiveness of a case area targeted water, sanitation, and hygiene (WASH) intervention in reducing cholera infections and increasing sustained WASH behaviors in transmission hotspots in a ring around cholera …
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Brain pacemaker trial aims to lift severe depression
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate the feasibility and safety of deep brain stimulation in treatment resistant depression. The main questions it aims to answer are: * Is deep brain stimulation effective in treating treatment resistant depression? * Does deep brain…
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC